摘要
前列腺癌(prostate cancer,PCa)是男性泌尿系统常见恶性肿瘤,我国PCa发病率低于欧美等发达国家,但呈逐年增长的趋势。PCa正严重影响着我国男性患者的健康。近年来随着对PCa发病机制的深入认识,许多新药应用于临床并改善了PCa的预后。
Prostate cancer is common malignant tumors of the male urinary system. It is the most common malignant tumor in men in developed countries. The incidence of prostate cancer in China is lower than that in developed countries such as Europe and America, but it is increasing year by year. Prostate cancer is seriously affecting the health of male patients in China. In recent years, with the understanding of the pathogenesis of prostate cancer, many new drugs have appeared in the clinic and improved the prognosis of prostate cancer.
作者
肖健
任明华
XIAO Jian;REN Minghua(Department of Urology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China)
出处
《临床与病理杂志》
2019年第1期188-192,共5页
Journal of Clinical and Pathological Research
关键词
前列腺癌
药物治疗
化疗
放疗
免疫治疗
信号通路抑制剂
整合素抑制剂
prostate cancer
drug therapy
chemotherapy
radiotherapy
immunotherapy
signaling pathway inhibitors
integrin inhibitors